Skip to main content

BNR · Burning Rock Biotech Ltd · Metrics

Track BNR — free
$13.32 +0.25 (+1.91%) At close · Nov 19 Q1 2024 earnings call transcript
Market Cap
$140.48M
Shares
10.55M
Volume · Nov 19 29.47K Avg daily vol (3M) 35.68K

BNR metrics

66 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.32
Market cap
$140.48M

Price action

23 metrics
Price change (1W)
-0.1%
Price change (30D)
-1.4%
Price change (3M)
+44.0%
Price change (6M)
-18.4%
Price change (YTD)
-33.9%
Price change (1Y)
-16.9%
Trailing year
Price change (5Y)
—
52-week high
$41.06
52-week low
$7.04
Change from 52-week high
-67.6%
Change from 52-week low
+89.2%
Annualized volatility
124.0%
Annualized volatility (3M)
114.4%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.9
RSI (14D)
52.5
Price vs SMA 50
-4.0%
Price vs SMA 200
-11.0%
Avg volume (3M)
35,675
Relative volume
0.8
Average dollar volume
$471,479

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
10.55M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 90.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.0×
reciprocal yield 51.0%
P / book
1.9
reciprocal yield 52.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-03-29

Profitability

9 metrics
Gross margin
74.6%
Operating margin
-13.0%
Trailing 12 months
Net margin
-13.6%
Gross profit (TTM)
$373.23M
Operating profit (TTM)
−$65.02M
Net income (TTM)
−$9.74M
Trailing 12 months
Diluted EPS (TTM)
$-0.93
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-3,561.48

Growth

11 metrics
Revenue growth YoY
-9.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$71.61M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-100.0%
Year over year · fewer shares
Revenue CAGR (3Y)
-1.4%
Revenue CAGR (5Y)
+4.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-13.7%
Return on assets
-9.1%
Debt / equity
0.0
Current ratio
3.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$61.17M
Latest balance sheet
Cash & equivalents
$61.43M
Total assets
$110.63M
Total debt
$265,287

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$1.75M
Capital expenditures (TTM)
—
R&D (TTM)
−$19.28M
SG&A (TTM)
−$43.40M
Stock compensation (TTM)
—
R&D / revenue
-27.0%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
17
13F filer change QoQ
0
Institutional ownership
16.1%
Conviction holders (share of 13F filers)
5.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.1%
Holder tenure
18.0
Price vs estimated holder cost
+25.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.1%

Short interest

3 metrics
Short interest
0.3%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
40 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1792267 CUSIP 12233L206 13F (30d) 19 filings 17 filers Visit website Investor relations